Stay updated on Secukinumab Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” was added above the blocked study record. The site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:22:31.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision changes from **v3.7.0** to **v3.7.1**. The page itself still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T20:55:17.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Access to the study record now results in a 403 Forbidden error, indicating restricted access rather than displaying the study details. The previously visible study content and related navigation appear to be replaced by the error page.
    Difference
    19%
    Check dated 2026-09-22T22:31:42.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a newer release of the site's underlying template used to display the study record. This is an internal platform update and does not alter the study content or its presentation.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.5 to v3.6.6, signaling a new build of the page. The study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-09-01T18:12:16.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    New NIH grant/contract identifier 2016 was added to the study's external identifiers (under Other Study ID Numbers), linking the trial to NIH funding. This addition provides funding attribution and improves traceability of the study's financial support.
    Difference
    0.1%
    Check dated 2026-08-25T20:39:40.000Z thumbnail image

Stay in the know with updates to Secukinumab Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secukinumab Efficacy in Atopic Dermatitis Clinical Trial page.